Volume 9 – Number 2

Development of Drug Resistance Mutations in Patients on Highly Active Antiretroviral Therapy: Does Competitive Advantage Drive Evolution

HIV Diversity, Recombination and Disease Progression: How Does Fitness “Fitâ€? Into the Puzzle?

HIV and Malaria

Update on the Treatment of Chronic Hepatitis C in HIV-infected Patients

A Brief History of TRIM5α

Discovery of VIRIP – a Natural HIV Entry Inhibitor

Efavirenz to Nevirapine Switch in HIV-Infected Patients with Dyslipidemia

SPRING: A New Trial to Evaluate Tipranavir in Heterogeneous Treatment-Experienced HIV Populations

HIV Guidelines

HIV Conferences